Cantor Fitzgerald Starts Eikon Therapeutics Inc. (EIKN) at Overweight
Tweet
Share
E-mailGet Alerts EIKN Hot Sheet
Price: $11.05 +6.97%
Rating Summary:
5 Buy, 0 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 0 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cantor Fitzgerald analyst Imogen Mansfield initiates coverage on Eikon Therapeutics Inc. (NASDAQ: EIKN) with a Overweight rating.
For an analyst ratings summary and ratings history on Eikon Therapeutics Inc. click here. For more ratings news on Eikon Therapeutics Inc. click here.
Shares of Eikon Therapeutics Inc. closed at $13.78 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stripe, Advent In Talks To Buy Paypal - WSJ
- Air T reports revenue jump but widens operating loss in Q1 fiscal 2027
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor Fitzgerald, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
